tert-butyl N-{8-aminobicyclo[3.2.1]octan-3-yl}carbamate

Catalog No.: 
ACTLJI069
CAS No.: 
1439905-12-0
Molecular Formula: 
C13H24N2O2
Molecular Weight: 
240.35
tert-butyl N-{8-aminobicyclo[3.2.1]octan-3-yl}carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$473.00InquiryInquiry
100mg95%$698.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-butyl N-{8-aminobicyclo[3.2.1]octan-3-yl}carbamate
IUPAC Nametert-butyl (8-aminobicyclo[3.2.1]octan-3-yl)carbamate
MDL No.MFCD25458140
Molecular FormulaC13H24N2O2
Molecular Weight240.35
SMILESO=C(OC(C)(C)C)NC1CC(C2N)CCC2C1
InChI KeyMUWURQCFDBXINK-UHFFFAOYSA-N
Synonymtert-butyl N-{8-aminobicyclo[3.2.1]octan-3-yl}carbamate;tert-butyl N-(8-amino-3-bicyclo[3.2.1]octanyl)carbamate;Carbamic acid, N-(8-aminobicyclo[3.2.1]oct-3-yl)-, 1,1-dimethylethyl ester;tert-butyl (8-aminobicyclo[3.2.1]octan-3-yl)carbamate
CAS No.1439905-12-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACTLJI069 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTLJI069 route product structure diagram
    ACTLJI0691439905-12-0
Inquiry

2. ACTLJI069 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTLJI069 route product structure diagram
    ACTLJI0691439905-12-0
Inquiry

3. ACTLJI069 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTLJI069 route product structure diagram
    ACTLJI0691439905-12-0
Inquiry

Comments (0)